Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Taisheng Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Datong, China, and operates as a key subsidiary of Sinopharm Weiqida Pharmaceutical. The company specializes in the research, development, and large-scale production of finished dosage forms, including sterile powder for injection, tablets, and capsules. Its primary focus is on anti-infective medications, particularly cephalosporin and penicillin antibiotics, which are manufactured in GMP-certified facilities. Beyond antibiotics, the company's portfolio includes treatments for cardiovascular, respiratory, and digestive system diseases. As part of the Sinopharm Group, Shanxi Taisheng Pharmaceutical leverages an extensive distribution network to supply high-quality medicines to both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Taisheng Pharmaceutical.